306 filings
Page 2 of 16
8-K
ih9l43h rza
1 Mar 23
Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates
7:01am
8-K
87wb5j ed
22 Feb 23
Regulation FD Disclosure
5:27pm
8-K
r5af0ia25x1l7dw4t
9 Jan 23
Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook
7:01am
8-K
gz5ayc6pfnmo958nojlo
28 Dec 22
Entry into a Material Definitive Agreement
5:00pm
8-K
bkt2457
16 Dec 22
Amicus Therapeutics Receives Positive CHMP Opinion for Pombilitiā¢ (cipaglucosidase alfa) for Late-Onset Pompe Disease
8:17am
8-K
526o25khkofv
16 Nov 22
Corporate OverviewNovember 2022At the Forefront of Therapies for Rare Diseases
7:01am
8-K
aq32df 8iabxk
7 Nov 22
Amicus Therapeutics Provides EU Regulatory Update for AT-GAA
2:31pm
8-K
dq1qihbh1q npue
7 Nov 22
Entry into a Material Definitive Agreement
7:22am
8-K
jl2uy
7 Nov 22
Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates
7:01am
8-K
nxxq958l 1j7z
28 Oct 22
U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease
5:18pm
8-K
wxxijpl a6w95yh
14 Sep 22
Corporate Overview September 2022 At the Forefront of Therapies for Rare Diseases
7:00am
8-K
ppz1n6ig
4 Aug 22
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
7:01am
8-K
73mb t94e3
1 Aug 22
Departure of Directors or Certain Officers
5:10pm
8-K
4gmzhfxga94o6wzxiiw
10 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
qiuhdi4r0jys
10 May 22
Amicus Therapeutics Receives Notification of PDUFA Date Extensions for AT-GAA
4:01pm
8-K/A
8xrmec6u9ze2xt a0xm
9 May 22
Amicus Therapeutics Announces First Quarter 2022 Financial Results
12:54pm
8-K
d1bcwbs
9 May 22
Amicus Therapeutics Announces First Quarter 2022 Financial Results
7:00am
8-K
3t3h3q3
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
8wk20
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
mq66rxcwyssg62bt
3 Dec 21
Other Events
7:00am